Stay updated on Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThis change updates the ClinicalTrials.gov page’s displayed revision/build label from v3.5.2 to v3.5.3, indicating a platform/version release rather than a study-record update.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe record history shows a new revision v3.5.0 added and revision v3.4.3 removed.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, reflecting the latest site release.SummaryDifference0.1%

- Check93 days agoChange DetectedOnly the site revision line changed: the history shows removal of Revision: v3.4.0 and addition of Revision: v3.4.1, indicating a background update rather than modifications to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.